A Phase 1, Single Centre, Open Label, Two-period Study in Healthy Volunteers to Determine the Effect of PBT2 on the Pharmacokinetics of Caffeine

Trial Profile

A Phase 1, Single Centre, Open Label, Two-period Study in Healthy Volunteers to Determine the Effect of PBT2 on the Pharmacokinetics of Caffeine

Completed
Phase of Trial: Phase I

Latest Information Update: 05 May 2016

At a glance

  • Drugs PBT 2 (Primary) ; Caffeine
  • Indications Alzheimer's disease; Huntington's disease
  • Focus Pharmacokinetics
  • Sponsors Prana Biotechnology
  • Most Recent Events

    • 31 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top